These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 26124208)
1. Feasibility and Acceptability of an Alcohol Addiction Therapy Integrated in a Transplant Center for Patients Awaiting Liver Transplantation. Erim Y; Böttcher M; Schieber K; Lindner M; Klein C; Paul A; Beckebaum S; Mayr A; Helander A Alcohol Alcohol; 2016 Jan; 51(1):40-6. PubMed ID: 26124208 [TBL] [Abstract][Full Text] [Related]
3. Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption. Staufer K; Andresen H; Vettorazzi E; Tobias N; Nashan B; Sterneck M Hepatology; 2011 Nov; 54(5):1640-9. PubMed ID: 21809364 [TBL] [Abstract][Full Text] [Related]
4. Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo. Dahl H; Hammarberg A; Franck J; Helander A Alcohol Alcohol; 2011; 46(5):553-7. PubMed ID: 21616946 [TBL] [Abstract][Full Text] [Related]
5. Urinary ethyl glucuronide and ethyl sulfate testing for detection of recent drinking in an outpatient treatment program for alcohol and drug dependence. Dahl H; Voltaire Carlsson A; Hillgren K; Helander A Alcohol Alcohol; 2011; 46(3):278-82. PubMed ID: 21339184 [TBL] [Abstract][Full Text] [Related]
6. Ethyl glucuronide (EtG): better than breathalyser or self-reports to detect covert short-term relapses into drinking. Wetterling T; Dibbelt L; Wetterling G; Göder R; Wurst F; Margraf M; Junghanns K Alcohol Alcohol; 2014; 49(1):51-4. PubMed ID: 24133131 [TBL] [Abstract][Full Text] [Related]
7. Liver transplantation for patients with alcoholism and end-stage liver disease. Gish RG; Lee AH; Keeffe EB; Rome H; Concepcion W; Esquivel CO Am J Gastroenterol; 1993 Sep; 88(9):1337-42. PubMed ID: 8362826 [TBL] [Abstract][Full Text] [Related]
8. Ethyl glucuronide for detecting alcohol lapses in patients with an alcohol use disorder. Lahmek P; Michel L; Diviné C; Meunier N; Pham B; Cassereau C; Aussel C; Aubin HJ J Addict Med; 2012 Mar; 6(1):35-8. PubMed ID: 21817916 [TBL] [Abstract][Full Text] [Related]
9. Detection times for urinary ethyl glucuronide and ethyl sulfate in heavy drinkers during alcohol detoxification. Helander A; Böttcher M; Fehr C; Dahmen N; Beck O Alcohol Alcohol; 2009; 44(1):55-61. PubMed ID: 18971292 [TBL] [Abstract][Full Text] [Related]
10. Assessing the drinking status of liver transplant patients with alcoholic liver disease. Allen JP; Wurst FM; Thon N; Litten RZ Liver Transpl; 2013 Apr; 19(4):369-76. PubMed ID: 23281299 [TBL] [Abstract][Full Text] [Related]
12. First report of a psychosocial intervention for patients with alcohol-related liver disease undergoing liver transplantation. Georgiou G; Webb K; Griggs K; Copello A; Neuberger J; Day E Liver Transpl; 2003 Jul; 9(7):772-5. PubMed ID: 12827568 [TBL] [Abstract][Full Text] [Related]
13. Ethyl glucuronide discloses recent covert alcohol use not detected by standard testing in forensic psychiatric inpatients. Wurst FM; Vogel R; Jachau K; Varga A; Alling C; Alt A; Skipper GE Alcohol Clin Exp Res; 2003 Mar; 27(3):471-6. PubMed ID: 12658113 [TBL] [Abstract][Full Text] [Related]
14. Ethyl sulphate: a direct ethanol metabolite reflecting recent alcohol consumption. Wurst FM; Dresen S; Allen JP; Wiesbeck G; Graf M; Weinmann W Addiction; 2006 Feb; 101(2):204-11. PubMed ID: 16445549 [TBL] [Abstract][Full Text] [Related]
15. Urinary ethyl glucuronide (EtG) and ethyl sulphate (EtS) assessment: valuable tools to improve verification of abstention in alcohol-dependent patients during in-patient treatment and at follow-ups. Junghanns K; Graf I; Pflüger J; Wetterling G; Ziems C; Ehrenthal D; Zöllner M; Dibbelt L; Backhaus J; Weinmann W; Wurst FM Addiction; 2009 Jun; 104(6):921-6. PubMed ID: 19466918 [TBL] [Abstract][Full Text] [Related]
16. Monitoring of the alcohol biomarkers PEth, CDT and EtG/EtS in an outpatient treatment setting. Helander A; Péter O; Zheng Y Alcohol Alcohol; 2012; 47(5):552-7. PubMed ID: 22691387 [TBL] [Abstract][Full Text] [Related]
17. Management of alcohol recurrence before and after liver transplantation. Marroni CA Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1():S109-14. PubMed ID: 26193869 [TBL] [Abstract][Full Text] [Related]
19. Hair ethyl glucuronide as a biomarker of alcohol consumption in alcohol-dependent patients: role of gender differences. Crunelle CL; Cappelle D; Covaci A; van Nuijs AL; Maudens KE; Sabbe B; Dom G; Michielsen P; Yegles M; Neels H Drug Alcohol Depend; 2014 Aug; 141():163-6. PubMed ID: 24928477 [TBL] [Abstract][Full Text] [Related]
20. Orthotopic liver transplantation for alcoholic liver disease: a retrospective analysis of survival, recidivism, and risk factors predisposing to recidivism. Mackie J; Groves K; Hoyle A; Garcia C; Garcia R; Gunson B; Neuberger J Liver Transpl; 2001 May; 7(5):418-27. PubMed ID: 11349262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]